1Fredriksson A, Archer T. Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice [J]. J Neural Transm Gen Sect, 1995,102 :19-34.
2Sundstrom E, Fredriksson A, Archer T. Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease [J]. Brain Res, 1990, 528:181-188.
3Fredriksson A, Plaznic A, Sundstrom E,et al. Effects of D1 and D2 agonists on spontaneous motor activity in MPTP treated mice [J]. Pharmacol Toxicol, 1994,75 : 36-41.
4Mohanakumar KP, Muralikrishnan D, Thomas B. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity [J ]. Brain Res, 2000,864 :281-290.
5Przedborski S, Jackson-Lewis V, Yokoyama R, et al. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine(MPTP)-induced dopaminergic neurotoxicity.[J]. PNAS, 1996,93:4565-4571.
6Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates[M]. San Diego : Academic, 1997.
7Ray J, Gage FH. Neural stem cell isolation, characterization and transplantation[A]. In: Windhorst U, Johansson H. Modern Techniques in Neuroscience Research[C]. Berlin Heidelberg: Springer-Verlag, 1999. 339-359.
8Li Y, Chen JL, Wang L,et al. Intracerebral transplantation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine mouse model of Parkinson's disease [J]. Neurosci Letters, 2001,316:67-70.
9Cosi C,Colpaert F,Koek W,et al. Poly(ADP-ribose) polymerase inhibitors protect against MPTP-induced depletions of striatal dopamine and cortical noradrenaline in C57BL/6 mice [J]. Brain Res, 1996,729 : 264-269.
10Horner PJ, Power AE, Kempermann G, et al. Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord[J]. J Neurosci, 2000,20 (6) : 2218- 2228.
